MAPK3 and leukemia: However, a study using human leukemia cells showed that activation of the RhoA/ROCK1 pathway decreased p-ERK1/2 in the nucleus, and inhibition of RhoA/ROCK1 led to accumulation of n-p-ERK1/249.